GMP 2026: Regulatory Reliance, AI, and the Future of Pharmaceutical Manufacturing

Join us in Basel for Sidley’s 2026 GMP Event, bringing together regulators, industry leaders, and practitioners for an international discussion on the latest developments shaping pharmaceutical manufacturing, quality, and compliance.

The discussions will look across Switzerland, the EU, and the United States at evolving regulatory expectations, inspection and enforcement trends, manufacturing and supply-chain challenges, and the technologies transforming GMP-regulated operations.

Featured Speakers and Panelists

• Christian Schärer, Head of Inspectorates, Swissmedic

Key Insights

• Reliance, Mutual Recognition, and Inspection Perspectives
  Explore the growing role of regulatory reliance and mutual recognition in GMP oversight and inspections, alongside inspection and enforcement trends, evolving regulatory expectations, and manufacturing and supply-chain challenges across Switzerland, the EU, and the United States.
• Innovation, Digital Transformation, and AI
  Discover how advanced manufacturing, automation, digital technologies, and AI are transforming pharmaceutical production and quality systems – and the evolving regulatory expectations around validation, data integrity, governance, and regulatory oversight.
• Looking Ahead
  Understand key regulatory developments, emerging technologies, and broader industry trends that are likely to shape GMP compliance and pharmaceutical manufacturing in 2027 and beyond.

Who Should Attend?
Executives, in-house counsel, quality and compliance managers and officers interested in and/or facing GMP compliance and quality management challenges in Switzerland.